Aptorum Group Correlations
APM Stock | USD 0.99 0.01 1.02% |
The current 90-days correlation between Aptorum Group and Unicycive Therapeutics is 0.06 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptorum Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptorum Group Ltd moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Aptorum Group Correlation With Market
Good diversification
The correlation between Aptorum Group Ltd and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aptorum Group Ltd and DJI in the same portfolio, assuming nothing else is changed.
Aptorum |
Moving together with Aptorum Stock
Moving against Aptorum Stock
0.48 | DTIL | Precision BioSciences | PairCorr |
0.37 | VANI | Vivani Medical | PairCorr |
0.31 | VKTX | Viking Therapeutics | PairCorr |
0.42 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.42 | EDIT | Editas Medicine | PairCorr |
0.4 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.4 | VRTX | Vertex Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aptorum Stock performing well and Aptorum Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aptorum Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ERYP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SRZN | 4.97 | 0.77 | 0.11 | 0.17 | 5.18 | 15.70 | 37.14 | |||
UNCY | 4.13 | 0.13 | 0.02 | 0.05 | 4.35 | 9.43 | 28.72 | |||
ARMP | 2.33 | (0.20) | 0.00 | 0.78 | 0.00 | 5.15 | 15.11 | |||
AMTI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
FRTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
AIM | 4.62 | (0.69) | 0.00 | 2.63 | 0.00 | 8.33 | 32.22 | |||
BCDA | 4.17 | 0.16 | 0.07 | (0.20) | 4.38 | 9.13 | 28.60 | |||
IPHA | 5.90 | 1.21 | 0.18 | 1.03 | 5.35 | 13.37 | 116.36 | |||
ADXN | 4.13 | (0.02) | 0.00 | (0.12) | 0.00 | 9.57 | 30.24 |
Aptorum Group Corporate Management
Wai Lee | Head RD | Profile | |
Martin Siu | Head Finance | Profile | |
Darren Lui | Chief CEO | Profile | |
Kwok Wong | Head Finance | Profile | |
Chung Huen | Founder Director | Profile | |
Clark Cheng | Chief Director | Profile |